However, in another study, miR-589-5p was found to inhibit the stemness of LIHC cancer stem cells (CSCs) through MAP3K8 and miR-589-5p down-regulation in LIHC is associated with a poor clinical prognosis [44]. The gene discussed is MAP3K8; the disease is cancer.